infections in Scotland remained undiagnosed. 5 A key aim of the Action Plan was to identify these undiagnosed individuals. Primary care was considered an appropriate setting to focus awareness-raising activities as previous studies have demonstrated increases in both testing and diagnoses as a result of targeted screening in the general practice setting. [6] [7] [8] [9] On a national level, a number of awareness-raising activities undertaken during pase II of the Action Plan (2008) (2009) (2010) (2011) were aimed specifically at GPs. 10 These included a Chief Medical Officer's letter, an information website for professionals (www.hepatitisscotland.org.
uk), adverts in the medical press and an information pack (including a leaflet, mouse mat and other items that prompted them to think of HCV and directing them to the website). The Royal College of general practitioners introduced a "Certificate in the Detection, Diagnosis and Management of Hepatitis B and C in Primary Care" delivered through online and face-to-face continued professional development (CPD) training in 2011. 11 Here, we present results of two surveys of GPs in 2007 and 2013 to i) describe GPs' testing practices, ii) examine changes in practice following the Action Plan and iii) determine physician-perceived barriers to HCV testing in primary care.
| MATERIALS AND METHODS

| GP survey population
GP training practices, where newly qualified doctors and medical students gain experience of general practice, were identified as an appropriate sample to survey in 2007 as contact details were readily available and in the public domain. 12 The training lead for each practice was asked to complete the survey. The training lead for all but two of the GP training practices throughout Scotland (n=235) was included in the survey; this represented 23% of all general practices in Scotland at that time (233/1030). Of the two excluded from the survey, one GP was on long-term sick leave and one addressee was unknown. To ascertain the urban/rural distribution of each practice, the Scottish Government classification scheme (2005) (2006) was employed. 13 The same GPs, regardless of whether they retained their training lead status, were surveyed in 2013. Seventeen GPs were not surveyed in 2013 as they had since moved practice (13) , retired (3) or were on maternity leave (1).
| Questionnaire
A questionnaire was designed to determine GPs' HCV testing practices using a combination of open and closed questions. This included questions on the characteristics of the GP's practice (NHS board and urban/rural category), whether the GP tests for HCV, how many HCV tests are undertaken per month, how many HCV patients diagnosed in the last year and the number of HCV patients currently under the GP's care. How frequently the offer on an HCV test would be made to key risk groups (as specified in the Scottish Intercollegiate Guidelines Network (SIGN) guidance) 14 was asked. Responses for this question used the scale "Always/almost always," "Usually," "About half the time," "Sometimes" or "Never/rarely." GP perceived barriers (i) associated with the client and (ii) associated with the practice were also asked and responses for this question used the scale "Strongly agree,"
"Agree," "Disagree" and "Strongly disagree."
Piloting of this questionnaire was undertaken with GPs associated with i) the Greater Glasgow and Clyde NHS Board Managed Care
Network and ii) the evaluation of a GP-based HCV screening interventions in Glasgow. 8, 9 The 2013 questionnaire included all of the questions from the 2007 questionnaire with the addition of questions to i) explore access to the Action Plan awareness-raising initiatives implemented following the initial survey and ii) whether the respondents considered future delivery of treatment through primary care may improve treatment uptake.
| Implementation of survey
The survey was implemented, during April/May 2007 and October/ November 2013, using Dillman's tailored design method. 15 This consisted of five key elements which have been shown to improve the response to postal surveys: i) a respondent-friendly questionnaire, ii)
five contacts with the questionnaire recipient during the survey period, iii) inclusion of a stamped addressed envelope, iv) personalized correspondence and v) a £15 book token as an incentive for completion of the questionnaire. The voluntary and confidential nature of the survey was emphasized. A copy of the survey was mailed to the GP(s) responsible for training in every practice.
| Data analysis
Data were managed and analysed using the Statistical Package for Social Sciences (SPSS) version 21.0 (IBM Corp. Armonk, NY, USA).
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Frequencies for each survey question were analysed. For analysis of frequency of key population groups offered an HCV test, answers were combined from five categories to three: "Always/Almost always/Usually," "About half the time/Sometimes" and "Never/Rarely." For analysis of barriers to HCV testing, answers were combined from four categories to two: "Strongly agree/Agree" and "Disagree/Strongly disagree." Where appropriate, the significance of any differences between the 2007 and 2013 was analysed using Kruskal-Wallis test or Fisher's exact test.
For 2013 responses, HCV training level was stratified into three categories: "CPD" (those who have undertaken a formal CPD course, for example courses provided by NHS Education Scotland or the Royal
College of General Practitioners), "Awareness raising" (those who reported receiving at least one of Chief Medical Officer's letter, Hepatitis C GP information pack, or online training resources and did not report CPD) and "None." The significance of any differences in the circumstances under which an HCV test was offered, and the likelihood of offering an HCV test to key population groups, across the three training levels was analysed using Kruskal-Wallis test. Where the significance of this was less than P=.05, a post hoc pairwise analysis was used to compare the significance among the training levels. A large proportion of the "None" group reported self-directed reading to ensure their HCV knowledge is current and so a sensitivity analysis comparing this group with the CPD group was undertaken.
| RESULTS
| Characteristics of surveyed GP training practices
The 
| HCV testing and diagnosis
Most respondents reported testing for HCV (91% in 2007 and 90% in 2013), almost all of whom reported testing fewer than 10 patients in an average month (98% in both surveys) ( Tables 1 and 2 ). Hepatitis Among those testing for HCV, more than 85% reported they would 
| Key populations to test for HCV
Variation of approach among GPs regarding the key populations to test for HCV was apparent ( 
| Barriers to testing
The surveys explored barriers to testing associated with the client as well as those associated with the practice as perceived by the responding GPs (Table 4) . Among barriers to testing related to the 
| Contact with hepatitis C awareness-raising and training initiatives
In 2013, more than half of respondents (57%) had heard of the Scottish Hepatitis C Action Plan. Of 2013 respondents, 25% reported having undertaken a formal CPD course, 59% reported being exposed to "Awareness raising" (having receiving at least one of Chief Medical
Officer's letter, Hepatitis C GP information pack or online training resources and did not report CPD), and 16% had received no HCV training or awareness raising.
| Differences in testing practice by contact with awareness-raising initiatives
Training level was found to be significantly associated with the proportion of respondents who reported "Always"/"Almost always"/"Usually" only for individuals who received medical/dental treatment in high HCV prevalence countries (39% for CPD, 15% for Awareness raising, 10%
for none, P=.002) ( Tables 5 and 6 ). In the pairwise analysis, the CPD and none of the group who had received no CPD or awareness raising (P=.012). In the pairwise analysis, only CPD compared with the None group was significant (P=.009).
For those who reported not attending or undertaking training/ CPD events for hepatitis C, almost three-quarters (73%) ensured their knowledge of hepatitis C was current through self-directed reading. A sensitivity analysis comparing this group with the CPD group found that the CPD group were significantly more likely to "Always"/"Almost always"/"Usually" offer at test to Current PWID (97% CPD, 75%
self-directed reading, P=.023) and those receiving medical/dental T A B L E 4 Barriers to hepatitis C testing associated with (A) the client and (B) the practice Respondents reported receiving at least one of Chief Medical Officer's letter, hepatitis C GP information pack or online training resources and did not report CPD.
*Results in bold are significant at the 95% level treatment in high prevalence countries (40% CPD, 13% self-directed reading, P=.003). Similarly, the CPD group was more likely to actively seek out risk factors (32% CPD, 0% self-directed reading, P=.005).
| Delivery of hepatitis C treatment in primary care
Eighty-one per cent (109/135) of respondents in 2013 agreed that delivery of new oral treatments for hepatitis C, which are more effective, shorter in duration and much better tolerated, in primary care could improve treatment uptake. Of the 19% who did not agree, concerns about resources, requirement of specialist support and the importance of training were indicated.
| DISCUSSION
| Summary of findings
Despite the first publication of the SIGN guidelines 15 on HCV in 2006, we found variation in GPs' testing practice across the key populations when surveyed the following year. While the proportion of respondents reporting that they would offer a test to current/former PWID and HIV-positive patients was high, the less common risk groups such as historical blood and blood products recipients or those who had received medical or dental treatment in high prevalence countries was considerably lower. Most respondents reported offering a test when presented with a risk or medical prompt but less than a quarter actively seek out risk factors for HCV.
Across the two surveys, despite numerous awareness-raising activ- The majority of respondents recalled being exposed to some form of HCV awareness raising, but only a minority had undertaken formal, HCV-related CPD. Among those who had undertaken CPD, actively seeking out risk factors and offering an HCV test to patients who had received medical/dental treatment in high prevalence countries were the only significant differences in practice than those who had not.
While this demonstrates some effectiveness of CPD, these improvements were modest and less than a third of the CPD group reported actively seeking risk factors. This is the optimal approach to case finding, particularly among those whose risk may not be immediately apparent, such as former PWID, or those who remain asymptomatic. None of the respondents who had received neither CPD nor awareness raising reported actively seeking out risk factors, and only 75% of this group would offer an HCV test to a current PWID. 
| Validity of observations
This is the first study to examine GPs' practices related to HCV in the context of a major government policy and investment. This article presents the views and practice prior to, and following, the Action Plan awareness-raising initiatives. A key limitation of this study is the inability to undertake a paired analysis across GPs responding twice.
As the 2007 survey was undertaken as part of a needs assessment project, it was not envisioned at that time that the survey would later be repeated. However, the 2007 survey provided the best available baseline data for knowledge and practice prior to the implementation of the awareness-raising campaigns.
The use of GP training leads may not be representative of the GP population in Scotland. The practices of the surveyed GPs were representative of all Scottish practices in terms of their NHS board affiliation and urban/rural distribution. However, given the likelihood that GP training practice staff will be kept informed of current guidelines for teaching purposes, although this will be the case for a wide variety of conditions rather than specializing in HCV, these results may indicate a high water mark of knowledge. A 2011 UK-wide survey of medical trainers (including GPs) found that GPs were responsible for a median of two trainees. Half reported having no additional contracted hours for such supervision but typically spend 3 hours a week on training. 17 This may limit the additional effort made on maintaining specific HCV skills. There will also be GPs with high HCV caseload, working in a high prevalence area or with a particular interest in HCV who may not have been surveyed but who have better HCV testing practice.
| Comparison with existing literature
Some previous studies reported poor knowledge of HCV among GPs, such as not incorrect interpretation of test results or the belief that blood transfusion continued to be a risk even after the introduction of screening. Generally, the proportion of GPs reporting that PWID should be offered an HCV test is in excess of 80% but this is reduced for the less common risk groups such as blood product recipients or sexual contacts, as is consistent with our results. Several of these studies also indicate that the offer of a test is suboptimally made as the GPs rarely actively seek risk factors. [18] [19] [20] [21] [22] None of these studies were in the context of a major policy such as the Scottish Hepatitis C Action Plan.
Our findings, particularly the high proportion of respondent agreeing that lack of time for pre-and post-test counselling is a barrier to testing and the low proportion of respondents actively seeking out risk factors, are consistent with a case-finding study in England, in which
GPs reported confidence in their knowledge of HCV but cited short consultation times and remembering to offer a test as the main barriers to testing. 23 That study suggested electronic reminders within the patient management system may increase the offer of an HCV test. A 2015 meta-analysis found that practitioner-based interventions that included in-practice support had the most impact on increasing test uptake (increasing by 3.5 times compared with no intervention) while media-or information-based campaigns had less impact (increase test uptake by 1.5 times compared with no intervention). 24 This is consistent with our findings that GPs who had undertaken CPD were more likely to actively seek out risk factors than those who had received no CPD or awareness raising.
| Significance of research
During the interval between the two surveys, the proportion of Scotland's HCV-infected population who were diagnosed was estimated to have increased from 38% to 55% 25, 26 ; one of the key drivers of the increase was the introduction of dried blood spot testing in community drug services for people who, generally, are still injecting drugs. 27, 28 It is estimated, however, that the majority of the 45% of HCV-infected people who remained undiagnosed as at 2013 were people who were no longer injecting. Thus, despite over 88% of GP's stating that they always offer an HCV test to someone they knew to have injected drugs in the past, thousands of former PWID in Scotland remain undiagnosed.
It is likely that many of these will have been to their GP at least once during the 6-year interval between surveys but identification would require actively seeking out their past injecting risk. Where the patient's injecting history was short or further in the past, it will be less likely that the risk is presented in an opportunistic manner.
Improved case finding among non-PWID groups is of particular importance in Scotland following the publication of the Penrose Inquiry
Final Report, which recommended that "the Scottish Government takes all reasonable steps to offer an HCV test to everyone in Scotland who had a blood transfusion before September 1991 and who has not been tested for HCV". 29 Our findings suggest the status quo would be insufficient to attain this goal and further targeted awareness raising among the patient group may also be required.
A growing body of evidence has demonstrated that significant increases in HCV screening can be achieved through electronic clinical reminders in patient management systems. 23, 30, 31 Such interventions are relatively easy to implement as they require one-off changes to the patient management system and can be rolled out across multiple users and practices. Similar increases in HCV testing have been observed following the introduction of a physical reminder attached to patient notes. 32 A qualitative analysis of HCV testing and diagnoses delay (where a diagnoses was more than 15 years after suspected transmission) found that patients may not believe themselves to be at risk and are less likely to volunteer risk information but prompts to discuss risks may increase testing. 33 Based on results from our study, an electronic reminder that encouraged a GP to ask about the patient's risk factors for HCV would remove the need for the GP to actively seek these out. Such an approach could be used to overcome the reported physician-perceived barriers of "poor awareness among staff" and "limited knowledge of testing protocols and who to be tested." This approach would have an impact on consultation times but for those individuals with a past risk, for example former PWID or historic blood transfusion recipients, it is likely that a one-off screening would be required. The SIGN guidelines for HCV recommend annual testing only for those who remain at risk of infection. also resulted in increases of HCV testing and diagnoses. 41 This study included a clinical nurse specialist and consistent with previously discussed findings that practice-based support interventions result in the largest increases in HCV testing and diagnoses. 8, 9, 24 The World Health Organization (WHO) has set a target for diagnosing 30% of HCV infections by 2020 and 90% by 2030. 42 The proportion of diagnosed infections varies by country, with some countries, such as Australia, in excess of 80%, and others, such as India, where it may be as low as 5%. 43, 44 Our results, based on the experience of the Scottish Action Plan, may be used to inform other countries seeking to meet the WHO targets. While directing funding to awareness-raising activities for GPs may result in some modest increases in testing and diagnoses in other countries, other more physician-centred measures should also be considered.
As we enter the era of DAA therapy, which offers both the possibility of control of hepatitis C and a move of treatment from secondary to primary care, the importance of general practitioners' HCV testing practice has never been more critical. The impact of government-led awareness-raising campaigns was limited, and it is clear that to identify the undiagnosed population, particularly those with a distant history of injecting drugs that is less likely to be apparent or the less common risk groups such as historic blood transfusion recipients, GPs require additional support and direction to expand HCV testing. Further measures, such as additional payments to GPs, electronic reminders or adoption of opt-out testing, should be considered alongside educational initiatives targeted at professionals and operate in tandem with awareness raising among at risk, or formerly at risk, groups.
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